Columbus Macro, LLC Vertex Pharmaceuticals Inc Transaction History

Columbus Macro, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$177.01 - $223.45 $286,225 - $361,318	-1,617 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$181.39 - $202.99 $181 - $202	-1 Reduced 0.06%	1,617 $293,000
Q2 2021 Jul 21, 2021	BUY	$187.49 - $221.1 $9,374 - $11,055	50 Added 3.19%	1,618 $326,000
Q1 2021 Apr 23, 2021	SELL	$207.02 - $241.31 $22,565 - $26,302	-109 Reduced 6.5%	1,568 $337,000
Q4 2020 Jan 26, 2021	BUY	$207.01 - $276.09 $145,114 - $193,539	701 Added 71.82%	1,677 $396,000
Q3 2020 Oct 30, 2020	BUY	$255.65 - $303.1 $249,514 - $295,825	976 New	976 $266,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Columbus Macro, LLC, based on Form 13F filings with the SEC.

Stay updated on Columbus Macro, LLC with notifications on news.